Gen Zers are getting increasingly near-sighted from staring at their electronic devices all day and face a blindness epidemic if they continue to stay indoors while phone-addicted, a leading eye ...

Global debate about how to navigate the climate crisis often centers on high-level pledges and whether national targets are being met. Yet focusing on these technical outcomes obscures a deeper ...

When myopia is considered a pathology Linking myopia to pathology prompted the World Health Organization (WHO) in 2019 to define the condition as a major risk factor for so-called preventable ...

Children living in heavily polluted cities could be at risk of going permanently blind, a study warns. Researchers recruited 30,000 school children in China and had them undergo a series of vision ...

The number of people with myopia, aka short-sightedness (difficulty seeing objects in the distance), has increased dramatically in recent years in various regions of the world. For example, in many ...

A newly discovered gene variant confers an increased risk for blindness and other complications of severe short-sightedness. Analysis of DNA from a large community-based cohort study first led to the ...

SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today ...

Macular degeneration, an eye disease that primarily affected the elderly, has recently surged among young people in their 20s and 30s. The analysis suggests that increased indoor activities and ...

Myopia – otherwise known as short-sightedness – used to be considered a hereditary inevitability. If your parents needed glasses, chances were, you would too. It was just the luck of the draw. But ...

Add Yahoo as a preferred source to see more of our stories on Google. Gen Zers are facing a looming blindness epidemic because of their increased use of electronic devices and lack of exposure to ...

SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today ...